GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Curatis Holding AG (CHIX:CURNz) » Definitions » EV-to-EBITDA

Curatis Holding AG (CHIX:CURNZ) EV-to-EBITDA : -1.28 (As of Sep. 23, 2024)


View and export this data going back to 2013. Start your Free Trial

What is Curatis Holding AG EV-to-EBITDA?

EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Curatis Holding AG's enterprise value is CHF64.52 Mil. Curatis Holding AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-50.26 Mil. Therefore, Curatis Holding AG's EV-to-EBITDA for today is -1.28.

The historical rank and industry rank for Curatis Holding AG's EV-to-EBITDA or its related term are showing as below:

CHIX:CURNz' s EV-to-EBITDA Range Over the Past 10 Years
Min: -1.93   Med: 0   Max: 0
Current: -1.28

CHIX:CURNz's EV-to-EBITDA is ranked worse than
100% of 712 companies
in the Drug Manufacturers industry
Industry Median: 13.99 vs CHIX:CURNz: -1.28

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

As of today (2024-09-23), Curatis Holding AG's stock price is CHF13.70. Curatis Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-176.378. Therefore, Curatis Holding AG's PE Ratio for today is At Loss.

The "classic" EV-to-EBITDA is much better in capturing debt and net cash than the PE Ratio.


Curatis Holding AG EV-to-EBITDA Historical Data

The historical data trend for Curatis Holding AG's EV-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Curatis Holding AG EV-to-EBITDA Chart

Curatis Holding AG Annual Data
Trend Dec21 Dec22 Dec23
EV-to-EBITDA
-968.07 -0.38 -0.01

Curatis Holding AG Semi-Annual Data
Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBITDA Get a 7-Day Free Trial - - -0.38 - -0.01

Competitive Comparison of Curatis Holding AG's EV-to-EBITDA

For the Drug Manufacturers - Specialty & Generic subindustry, Curatis Holding AG's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Curatis Holding AG's EV-to-EBITDA Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Curatis Holding AG's EV-to-EBITDA distribution charts can be found below:

* The bar in red indicates where Curatis Holding AG's EV-to-EBITDA falls into.



Curatis Holding AG EV-to-EBITDA Calculation

Curatis Holding AG's EV-to-EBITDA for today is calculated as:

EV-to-EBITDA=Enterprise Value (Today)/EBITDA (TTM)
=64.521/-50.26
=-1.28

Curatis Holding AG's current Enterprise Value is CHF64.52 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Curatis Holding AG's EBITDA for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-50.26 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Curatis Holding AG  (CHIX:CURNz) EV-to-EBITDA Explanation

EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.

Curatis Holding AG's PE Ratio for today is calculated as:

PE Ratio=Share Price (Today)/Earnings per Share (Diluted) (TTM)
=13.70/-176.378
=At Loss

Curatis Holding AG's share price for today is CHF13.70.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Curatis Holding AG's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was CHF-176.378.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Curatis Holding AG EV-to-EBITDA Related Terms

Thank you for viewing the detailed overview of Curatis Holding AG's EV-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.


Curatis Holding AG Business Description

Traded in Other Exchanges
Address
Hochbergerstrasse 60C, Technologiepark Basel, Basel, CHE, 4057
Kinarus Therapeutics Holding AG In Liquidation Formerly Kinarus Therapeutics Holding AG is a clinical-stage pharmaceutical company focused on bringing novel treatments to patients suffering from viral, respiratory, and ophthalmic diseases. The company's therapeutic drug candidate, KIN001, consists of a clinical-stage p38 mitogen-activated protein kinase (p38 MAPK) inhibitor, in-licensed from Roche, combined with a marketed drug, together enabling an oral, long-term effective treatment for patients suffering from diseases with serious impact on quality of life.

Curatis Holding AG Headlines

No Headlines